1. Home
  2. TVTX vs HLIT Comparison

TVTX vs HLIT Comparison

Compare TVTX & HLIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVTX
  • HLIT
  • Stock Information
  • Founded
  • TVTX 2008
  • HLIT 1988
  • Country
  • TVTX United States
  • HLIT United States
  • Employees
  • TVTX N/A
  • HLIT N/A
  • Industry
  • TVTX Biotechnology: Pharmaceutical Preparations
  • HLIT Radio And Television Broadcasting And Communications Equipment
  • Sector
  • TVTX Health Care
  • HLIT Technology
  • Exchange
  • TVTX Nasdaq
  • HLIT Nasdaq
  • Market Cap
  • TVTX 1.3B
  • HLIT 1.2B
  • IPO Year
  • TVTX N/A
  • HLIT 1995
  • Fundamental
  • Price
  • TVTX $14.92
  • HLIT $8.90
  • Analyst Decision
  • TVTX Strong Buy
  • HLIT Buy
  • Analyst Count
  • TVTX 13
  • HLIT 6
  • Target Price
  • TVTX $33.75
  • HLIT $12.50
  • AVG Volume (30 Days)
  • TVTX 2.0M
  • HLIT 1.2M
  • Earning Date
  • TVTX 05-05-2025
  • HLIT 04-28-2025
  • Dividend Yield
  • TVTX N/A
  • HLIT N/A
  • EPS Growth
  • TVTX N/A
  • HLIT N/A
  • EPS
  • TVTX N/A
  • HLIT 0.33
  • Revenue
  • TVTX $233,175,000.00
  • HLIT $678,722,000.00
  • Revenue This Year
  • TVTX $68.31
  • HLIT N/A
  • Revenue Next Year
  • TVTX $55.65
  • HLIT $22.41
  • P/E Ratio
  • TVTX N/A
  • HLIT $26.97
  • Revenue Growth
  • TVTX 60.55
  • HLIT 11.65
  • 52 Week Low
  • TVTX $5.12
  • HLIT $7.91
  • 52 Week High
  • TVTX $25.29
  • HLIT $15.46
  • Technical
  • Relative Strength Index (RSI)
  • TVTX 37.07
  • HLIT 40.27
  • Support Level
  • TVTX $14.13
  • HLIT $8.74
  • Resistance Level
  • TVTX $15.23
  • HLIT $9.17
  • Average True Range (ATR)
  • TVTX 1.31
  • HLIT 0.44
  • MACD
  • TVTX -0.10
  • HLIT 0.03
  • Stochastic Oscillator
  • TVTX 31.70
  • HLIT 54.10

About TVTX Travere Therapeutics Inc.

Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on identifying, developing and delivering life-changing therapies to people living with rare kidney, liver, and metabolic diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN)-rare kidney disorders that often cause end-stage kidney disease.

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

Share on Social Networks: